Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an...
Transcript of Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an...
![Page 1: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/1.jpg)
Introduction to IMI
Michel Goldman, MD, PhD Executive Director
![Page 2: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/2.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
2 Billion Euro
1 Billion €
1 Billion €
Public Private
Partnership
Innovative Medicines Initiative: Joining forces in the healthcare sector
![Page 3: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/3.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
• Open collaboration in final consortia
• Non-competitive research for EFPIA companies
• Competitive calls for IMI beneficiaries
Key Concepts
![Page 4: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/4.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
A typical IMI consortium
Private
Investment
In kind
EU Public
Funding
cash
EFPIA
ACADEMIA
HOSPITALS
PATIENTS’ ORGANISATIONS
SMALL AND MEDIUM-SIZED ENTERPRISES
REGULATORS
Pharma 1
Pharma 2
Pharma 3
Pharma 4
Pharma 5
Pharma 6
![Page 5: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/5.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
Building an IMI Project
Submission of
Expressions of Interest
First Peer review
First ranked consortium
Invitation to submit
Full Project Proposal
Competition
between
applicants’
consortia (potential IMI beneficiaries)
• By applicants’ consortia
(academics, SMEs, Patient org….)
• Independ. experts + EFPIA coordin.
• Independ. experts
• Approved by IMI Governing Board
• to first ranked applicants’ consortium
+ EFPIA consortium
assessment
ranking
![Page 6: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/6.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
• Looking for additional funding
• Interested in patient-centric biomedical/pharmaceutical research • Interested in collaborating with large pharmaceutical companies
Why apply ?
![Page 7: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/7.jpg)
Overview of IMI projects
* Small and medium-sized enterprises
![Page 8: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/8.jpg)
Key deliverables of non-competitive research
• Establishment of common databases
• New tools for identification of drug targets
• Standardization of models and assays
for drug efficacy and safety
• Patient reported outcomes
• Classification of diseases
![Page 9: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/9.jpg)
U-BIOPRED
Paves the way towards a new classification of asthma and personalized treatments for patients
38 Partners
- 9 EFPIA companies
- 23 Academic institutions
- 3 Patients’ organizations
- 3 SMEs
A new stepwise algorithm for the stratification
of patients with severe asthma
First achievements
Thorax, 66: 910-7 (2011)
![Page 10: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/10.jpg)
PRO-ACTIVE
Activity Monitor
PDA for E-PRO
Amount of activities
Symptoms / other dimensions
Sym
pto
ms
Ad
ap
tati
on
s /
PA
Time (days)
![Page 11: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/11.jpg)
Education & Training (1/2)
• Eu2P: online training: Master in Pharmacovigilance and
Pharmacoepidemiology
first courses started Autumn 2011
applications now open for Autumn 2012 intake
• SafeSciMET: training courses in drug safety
9 courses held in 2011
applications now open for six new courses (Leiden, Guildford, Copenhagen, Basel, Lyon, Stockholm)
![Page 12: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/12.jpg)
Education & Training (2/2)
• PharmaTrain: pan-European network for training in
Medicines Development
European Training Syllabus for Pharmaceutical Medicine
Accreditation of Centres of Excellence: shared standards
Expanding to academic network in Eastern-EU countries
• EMTRAIN: E&T platform covering entire drug life cycle
On-Course: biomedical post-graduate course catalogue = the most comprehensive portal in medical R&D courses in Europe
![Page 13: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/13.jpg)
SMEs in ongoing projects
![Page 14: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/14.jpg)
IMIDIA
![Page 15: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/15.jpg)
eTOX
Builds a large searchable database containing drug toxicity-related data extracted from relevant pharmaceutical pre-clinical legacy reports
Develops innovative methodological strategies and novel software tools to better predict in silico the toxicological profiles of new molecular entities in early stages of the drug development pipeline, using its database background
25 Partners
– 13 EFPIA companies
– 8 Public organisations
– 4 SMEs
J. Chem. Inf. Model. 51:483-92 (2011)
An innovative multi-scale modelling strategy
for the prediction of cardiotoxicity has been developed,
successfully tested and published
First achievements
![Page 16: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/16.jpg)
eTOX: A key role for SME
Nature Biotechnology, 29: 789, 2011
![Page 17: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/17.jpg)
Clinical Pharmacology & Therapeutics March 2012,
http://www.nature.com/doifinder/10.1038/clpt.2011.321
![Page 18: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/18.jpg)
Overall project achievements
• Over 45 scientific peer-reviewed publications
in 38 different journals
median impact factor 5.192
• 89 % of projects reported at least 75 % of milestones
achieved
5th Call Open Info Day - 27/02/2012 - Brussels
![Page 19: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/19.jpg)
Call 5 Time line
• Open Info Day 27 Feb 2012
• Call Launch early March 2012
• Stage 1 submission deadline 16 May 2012
• Decision on EoIs ranking 29 Jun 2012
• Stage 2 submission deadline 13 Sept 2012
• Decision on FPPs 01 Oct 2012
• Grant Agreement signature end Dec 2012
5th Call Open Info Day - 27/02/2012 - Brussels
![Page 20: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/20.jpg)
Find project partners
5th Call Open Info Day - 27/02/2012 - Brussels
• IMI Partner Search Tool: www.imi.europa.eu/content/partner-search
• IMI States Representatives Group (SRG) member: www.imi.europa.eu/content/states-representatives-groups
• Health National Contact Point (NCP): cordis.europa.eu/fp7/health/ncp_en.html
![Page 21: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/21.jpg)
Keep up to date
5th Call Open Info Day - 27/02/2012 - Brussels
• Webinar: 5 March 2012
• Visit www.imi.europa.eu
• Sign up to the IMI Newsletter
• Follow us on Twitter: @IMI_JU
• Join the Innovative Medicines Initiative group on LinkedIn
• Questions? E-mail us: [email protected]
![Page 22: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/22.jpg)
Future Call topic
5th Call Open Info Day - 27/02/2012 - Brussels
• NewDrugs4BadBugs:
Tackling resistance to antibiotics:
building partnerships to progress the discovery and development
of novel antibiotic drugs to treat the most urgent infections
Preliminary outline available on www.imi.europa.eu
![Page 23: Introduction to IMI - imi.europa.eu · 5th Call Open Info Day - 27/02/2012 - Brussels Building an IMI Project Submission of Expressions of Interest First Peer review First ranked](https://reader035.fdocuments.in/reader035/viewer/2022062507/5fc7149bb3147f651752bc60/html5/thumbnails/23.jpg)
5th Call Open Info Day - 27/02/2012 - Brussels
Thank you !